Introduction: Revisional bariatric surgery (RBS) for insufficient weight loss/weight regain or metabolic relapse is increasing worldwide. There is currently no large multinational, prospective data on 30-day morbidity and mortality of RBS. In this study, we aimed to evaluate the 30-day morbidity and mortality of RBS at participating centres. Methods: An international steering group was formed to oversee the study. The steering group members invited bariatric surgeons worldwide to participate in this study. Ethical approval was obtained at the lead centre. Data were collected prospectively on all consecutive RBS patients operated between 15th May 2021 to 31st December 2021. Revisions for complications were excluded. Results: A total of 65 global centres submitted data on 750 patients. Sleeve gastrectomy (n = 369, 49.2 %) was the most common primary surgery for which revision was performed. Revisional procedures performed included Roux-en-Y gastric bypass (RYGB) in 41.1 % (n = 308) patients, One anastomosis gastric bypass (OAGB) in 19.3 % (n = 145), Sleeve Gastrectomy (SG) in 16.7 % (n = 125) and other procedures in 22.9 % (n = 172) patients. Indications for revision included weight regain in 615(81.8 %) patients, inadequate weight loss in 127(16.9 %), inadequate diabetes control in 47(6.3 %) and diabetes relapse in 27(3.6 %). 30-day complications were seen in 80(10.7 %) patients. Forty-nine (6.5 %) complications were Clavien Dindo grade 3 or higher. Two patients (0.3 %) died within 30 days of RBS. Conclusion: RBS for insufficient weight loss/weight regain or metabolic relapse is associated with 10.7 % morbidity and 0.3 % mortality. Sleeve gastrectomy is the most common primary procedure to undergo revisional bariatric surgery, while Roux-en-Y gastric bypass is the most commonly performed revision.
Introduction: Revisional bariatric surgery (RBS) for insufficient weight loss/weight regain or metabolic relapse is increasing worldwide. There is currently no large multinational, prospective data on 30-day morbidity and mortality of RBS. In this study, we aimed to evaluate the 30-day morbidity and mortality of RBS at participating centres. Methods: An international steering group was formed to oversee the study. The steering group members invited bariatric surgeons worldwide to participate in this study. Ethical approval was obtained at the lead centre. Data were collected prospectively on all consecutive RBS patients operated between 15th May 2021 to 31st December 2021. Revisions for complications were excluded. Results: A total of 65 global centres submitted data on 750 patients. Sleeve gastrectomy (n = 369, 49.2 %) was the most common primary surgery for which revision was performed. Revisional procedures performed included Roux-en-Y gastric bypass (RYGB) in 41.1 % (n = 308) patients, One anastomosis gastric bypass (OAGB) in 19.3 % (n = 145), Sleeve Gastrectomy (SG) in 16.7 % (n = 125) and other procedures in 22.9 % (n = 172) patients. Indications for revision included weight regain in 615(81.8 %) patients, inadequate weight loss in 127(16.9 %), inadequate diabetes control in 47(6.3 %) and diabetes relapse in 27(3.6 %). 30-day complications were seen in 80(10.7 %) patients. Forty-nine (6.5 %) complications were Clavien Dindo grade 3 or higher. Two patients (0.3 %) died within 30 days of RBS. Conclusion: RBS for insufficient weight loss/weight regain or metabolic relapse is associated with 10.7 % morbidity and 0.3 % mortality. Sleeve gastrectomy is the most common primary procedure to undergo revisional bariatric surgery, while Roux-en-Y gastric bypass is the most commonly performed revision.
30-day morbidity and mortality of revisional bariatric surgery – An international multi-centre collaborative (BROAD) study / Nasta, A. M.; Goel, R.; Singhal, R.; Lemmens, L.; Baig, S.; Seki, Y.; Prasad, A.; Chiappetta, S.; Kermansaravi, M.; Vertruyen, M.; Pascotto, B.; Azagra, J. S.; Al-Khyatt, W.; Martines, G.; Villao, D. Y.; Revello, L.; Rioseco, M.; Martini, F.; Liagre, A.; Juglard, G.; Dapri, G.; Proczko-Stepaniak, M. A.; ABOU-MRAD, A. K.; Elghadban, H. M.; Stier, C.; Van Herck, J. L. E.; Taha, S. A.; Sen, O.; Dillemans, B.; Van Hoef, S.; Vandeputte, M.; Viskens, S.; Gentileschi, P.; Palaniappan, R.; Sakran, N.; Shin, T. H.; Aminian, A.; Uccelli, M.; Olmi, S.; Cesana, G. C.; Anselmino, M.; Debergh, N. P. A.; Gartner, D.; Yang, W.; Bedi, D. S.; Mahawar, K.; Abdalah, H.; Hamid, H.; Gianchandani-Moorjani, R.; Bottino, V.; Bosco, A.; Napolitano, E.; Mamidanna, R.; Madhok, B.; Acin-Gandara, D.; Medina-Garcia, M.; Kumar, S.; Bankenahally, R.; Sarfaraz, Y.; Fry, H.; Wiggins, T.; Yarlagadda, K.; Popp, A.; Pintar, T.; Mulita, F.; Verras, G. -I.; Vailas, M.; Skroubis, G.; Khaitan, M.; Lezoche, G.; Pfefferkorn, U.; Shahabi, S.; Davarpanah, A.; Wang, C.; Dong, Z.; Gordejuela, A. G. R. D.; Vilallonga, R.; Gonzalez, O.; Major, P.; Zarzycki, P.; Rymarowicz, J.; Nijs, Y.; Palep, J.; Wadhawan, R.; Veetil, D. K.; Esquivel, C.; Garcia, M.; Lascano, F. M.; Muriel, M.; Foscarini, J.; Nassour, F.; Kasama, K.; Duro, A.; Kim, S. H.; Inam, A.; Sharma, S.; Kassir, R.; Avalos, M. A.; Alsareii, S.; Vladimirov, M.; Campanelli, M.; Benavoli, D.; Bianciardi, E.; Sebastian-Tomas, J. C.; Trullenque-Juan, R.; Diez-Ares, J. A.; Viveiros, O.; Ribeiro, R.; Al, M.; Gokhan, A.; Krishna, N.; Haj, B.; Gfely, R.; Arraf, J.; Omari, A.; Awad, A.; Gupt, P.; Himpens, J.; Super, J.; Charalampakis, V.; Daskalakis, M.; Sahloul, M.; Kapoulas, S.; Rawashdeh, A.; Sillah, K.; Raghuraman, G.; Navarro, A. G.; Kosai, N. R.; Ani, M. F. C.. - In: OBESITY RESEARCH & CLINICAL PRACTICE. - ISSN 1871-403X. - 18:3(2024), pp. 195-200. [10.1016/j.orcp.2024.06.001]
30-day morbidity and mortality of revisional bariatric surgery – An international multi-centre collaborative (BROAD) study
Chiappetta S.;Olmi S.;Cesana G. C.;Bottino V.;
2024-01-01
Abstract
Introduction: Revisional bariatric surgery (RBS) for insufficient weight loss/weight regain or metabolic relapse is increasing worldwide. There is currently no large multinational, prospective data on 30-day morbidity and mortality of RBS. In this study, we aimed to evaluate the 30-day morbidity and mortality of RBS at participating centres. Methods: An international steering group was formed to oversee the study. The steering group members invited bariatric surgeons worldwide to participate in this study. Ethical approval was obtained at the lead centre. Data were collected prospectively on all consecutive RBS patients operated between 15th May 2021 to 31st December 2021. Revisions for complications were excluded. Results: A total of 65 global centres submitted data on 750 patients. Sleeve gastrectomy (n = 369, 49.2 %) was the most common primary surgery for which revision was performed. Revisional procedures performed included Roux-en-Y gastric bypass (RYGB) in 41.1 % (n = 308) patients, One anastomosis gastric bypass (OAGB) in 19.3 % (n = 145), Sleeve Gastrectomy (SG) in 16.7 % (n = 125) and other procedures in 22.9 % (n = 172) patients. Indications for revision included weight regain in 615(81.8 %) patients, inadequate weight loss in 127(16.9 %), inadequate diabetes control in 47(6.3 %) and diabetes relapse in 27(3.6 %). 30-day complications were seen in 80(10.7 %) patients. Forty-nine (6.5 %) complications were Clavien Dindo grade 3 or higher. Two patients (0.3 %) died within 30 days of RBS. Conclusion: RBS for insufficient weight loss/weight regain or metabolic relapse is associated with 10.7 % morbidity and 0.3 % mortality. Sleeve gastrectomy is the most common primary procedure to undergo revisional bariatric surgery, while Roux-en-Y gastric bypass is the most commonly performed revision.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
